ES2055657B1 - Derivados de bencenosulfonamida. - Google Patents

Derivados de bencenosulfonamida.

Info

Publication number
ES2055657B1
ES2055657B1 ES9202004A ES9202004A ES2055657B1 ES 2055657 B1 ES2055657 B1 ES 2055657B1 ES 9202004 A ES9202004 A ES 9202004A ES 9202004 A ES9202004 A ES 9202004A ES 2055657 B1 ES2055657 B1 ES 2055657B1
Authority
ES
Spain
Prior art keywords
alkyl
derivatives
xbs2
xbs1
abs3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9202004A
Other languages
English (en)
Other versions
ES2055657A1 (es
Inventor
Philip Neil Edwards
Keith Oldham
David Waterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Imperial Chemical Industries Ltd
Original Assignee
ICI Pharma SA
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Pharma SA, Imperial Chemical Industries Ltd filed Critical ICI Pharma SA
Priority to ES9202004A priority Critical patent/ES2055657B1/es
Publication of ES2055657A1 publication Critical patent/ES2055657A1/es
Application granted granted Critical
Publication of ES2055657B1 publication Critical patent/ES2055657B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

DERIVADOS DE BENCENOSULFONAMIDA DE FORMULA I FORMULA EN DONDE RBS1 SC ES ALQUILO 1-4C, ALQUENILO 3-4C O ALQUINILO 34C; RBS2 SC Y RBS3 SC FORMAN JUNTOS --ABS2 SC-XBS2 SC-ABS3 SC-- EL CUAL DEFINE UN ANILLO DE 5 O 6 ATOMOS EN EL ANILLO, EN DONDE ABS2 SC Y ABS3 SC SON CADA UNO ALQUILENO 1-3C, Y XBS2 SC ES OXI, TIO, SULFINILO O SULFONILO; AL ES UN ENLACE DIRECTO A XBS1 SC O ES ALQUILENO 1-3C; XBS1 SC ES OXI, TIO O IMINO; AR ES FENILENO EN CASO DADO SUBSTITUIDO; RBS4 SC ES ALQUILO 1-4C, FLUOR-ALQUILO 2-4C O FENILO EN CASO DADO SUBSTITUIDO O UNA MITAD HETEROCICLICA; RBS5 SC ES HIDROGENO O ALQUILO 1-4C; Y RBS6 SC ES HIDROGENO, HALOGENO, TRIFLUORMETILO, ALQUILO 1-4C O ALCOXI 1-4C; O SUS SALES FARMACEUTICAMENTE ACEPTABLES. TALES DERIVADOS SON DE UTILIDAD COMO INHIBIDORES DE 5-LIPOXIGENASA.
ES9202004A 1992-10-08 1992-10-08 Derivados de bencenosulfonamida. Expired - Fee Related ES2055657B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9202004A ES2055657B1 (es) 1992-10-08 1992-10-08 Derivados de bencenosulfonamida.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9202004A ES2055657B1 (es) 1992-10-08 1992-10-08 Derivados de bencenosulfonamida.

Publications (2)

Publication Number Publication Date
ES2055657A1 ES2055657A1 (es) 1994-08-16
ES2055657B1 true ES2055657B1 (es) 1995-02-16

Family

ID=8278360

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9202004A Expired - Fee Related ES2055657B1 (es) 1992-10-08 1992-10-08 Derivados de bencenosulfonamida.

Country Status (1)

Country Link
ES (1) ES2055657B1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018134D0 (en) * 1989-09-29 1990-10-03 Ici Plc Heterocyclic derivatives
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
AU645159B2 (en) * 1991-01-17 1994-01-06 Ici Pharma Sulphonamide derivatives

Also Published As

Publication number Publication date
ES2055657A1 (es) 1994-08-16

Similar Documents

Publication Publication Date Title
CO4520226A1 (es) Compuestos carbociclicos
ES2079576T3 (es) Derivados piranicos biciclicos y su uso como inhibidores de 5-lipoxigenasa.
DE59207601D1 (de) Verwendung von Sulfonamiden als Heilmittel und neue Sulfonamide
DE59209872D1 (de) Sulfonamide, ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte
KR840006237A (ko) 설포닐 우레아의 제조방법
DE69528198D1 (de) Aryl-und hetaryl-sulfonamid derivate, deren herstellung und deren verwendung als endothelin-antagonisten
ATE97914T1 (de) Perhydrothiazepinderivate, ihre herstellung und ihre therapeutische verwendung.
DK271388A (da) Oxetanocinereller farmakologisk acceptable salte deraf samt deres anvendelse
FI811373L (fi) Substituerade fenyletrar
FI864618A0 (fi) Nya 3-oxadiazol- och 3-karboksylsyra- -karbolinderivat, deras framstaellning och deras anvaendning som laekemedel.
ES2055657B1 (es) Derivados de bencenosulfonamida.
DE3869289D1 (de) Antiarrhythmische mittel auf basis von sulfonamiden.
EA200400758A1 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
IT1207057B (it) Policarbonati ramificati contenenti 2,4,6-tris(4'-idrossiaril)-ammino-s-triazine.
FI915979A (fi) Fenylalkylaminoalkylfoereningar samt foerfaranden foer deras framstaellning och laekemedel som innehaoller dessa foereningar.
EP0521101A1 (en) Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
ATE116645T1 (de) Chromenderivate, deren herstellung und verwendung.
DK0466662T3 (da) 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser
DE69301644D1 (de) 1-Alkoxy-naphtalen-2-carboxamid-Derivate mit hoher Affinität für das 5-HT1A Rezeptor von Serotonin
ES2103675B1 (es) Nuevas piperidinas sustituidas.
NO963854D0 (no) Okulart spenningsnedsettende middel
ES2129784T3 (es) Procedimiento de preparacion de un compuesto intermediario de sintesis y su uso.
DE69011714D1 (de) Kalziumantagonisten.
ES8800663A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
ATE99306T1 (de) Antagonisten von leukotrien d4.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201